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Atenolol prevents the formation of expansive hematoma after
rhytidoplasty
O atenolol previne a formação de hematoma expansivo após ritidoplastia
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A B S T R A C T
Objective: To evaluate the perioperative use of atenolol in reducing the incidence of hematoma after rhytidoplasty. Methods:
Between January 2007 and February 2013, 80 patients were randomized into two groups: Group A (n = 26) received perioperative
atenolol in order to maintain heart rate (PR) around 60 per minute; Group B (n = 54) did not receive atenolol. Both groups underwent
the same anesthetic and surgical technique. We monitored blood pressure (BP), HR, hematoma formation and the need for
drainage. Patients were followed-up until the 90th postoperative day. The variables were compared between the groups using the
ANOVA test. Continuous variables were presented as mean ± standard deviation and the differences were compared with the
Student’s t test. Values of p d” 0.05 were considered significant. Results: In group A the mean BP (110-70mmHg ± 7.07) and HR
(64 / min ± 5) were lower (p d” 0.05) than in group B (135-90mmHg ± 10.6) and (76 / min ± 7.5), respectively. There were four cases
of expansive hematoma in group B, all requiring reoperation for drainage, and none in group A (p d” 0,001). Conclusion: The
perioperative use of atenolol caused a decrease in blood pressure and heart rate and decreased the incidence of expanding
hematoma after rhytidectomy.
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INTRODUCTION
One of the major postoperative complications ofrhytidectomy is the expansive hematoma. Its
occurrence can reach up to 16% 1 and affects postoperative
recovery, is associated with increased swelling and bruising
and, in some cases, can lead to ischemia, infection, and
necrosis of the operating area 2. Furthermore, the extension
of healing time (inflammatory phase) predisposes to
cicatricial changes such as hyperpigmentation, scar
hypertrophy, keloid formation and scarring in the
subcutaneous tissue.
After revision of 1,078 rhytidectomies, the
occurrence of expansive hematoma was attributed to several
factors: plication and / or detachment of the platysma, high
systolic blood pressure, male gender, use of aspirin and / or
anti-inflammatory agents, and smoking 3.
Many surgical approaches have been suggested
for the prevention of this complication, most only of local
action, such as external stitches2, use of suction drains4,
tumescent infiltration4, tissue glues5, dissection with
ultrasonic instruments6 and internal adhesion stitches7.
The occurrence of hematoma associated with
high systolic blood pressure, nausea, vomiting, agitation,
anxiety and pain has been repeatedly reported 8,9. Non-
surgical preventive measures to control this manifestation
were suggested, but only during the first 24 hours 10.
Most patients of cosmetic surgeries are or
becomes anxious (because of the surgical procedure itself),
which, in general, increases heart rate (HR) and systolic
blood pressure. In addition, most patients seeking facial
rejuvenation have increased blood pressure levels (BP) due
to the age.
Thus, we have decided to use the beta-blocker
atenolol since the preoperative period and keep it until the
15th day postoperatively (PO) and associate its use to
preventive measures, following a protocol of clinical care
in a group of selected patients and compare them to a
control group submitted to the same protocol, but without
the drug atenolol, whether  per- or postoperatively.
METHODS
After approval of the Ingá Faculty (Uningá) Ethics
Committee, we randomly and prospectively selected 80
patients undergoing rhytidectomy in the Maringá
Plasticlínica (Paraná State – PR, Brazil) between January
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2007 and February 2013. There was no restriction of range
age. Inclusion criteria were: men or women who needed
facelift without distinction of ethnicity or age. Exclusion
criteria were: coagulation disorders, use of anticoagulants,
smoking, routine use of beta-blockers and decompensated
hypertension.    The preoperative preparation followed a
strict clinical routine, detailed analysis of the drugs in use,
with attention to morbid or allergic history, laboratory tests,
pre-anesthetic consultation and photographic
documentation. We divided the patients into two groups:
Group A (study), which preoperatively received oral atenolol
at a single dose of 25 to 100 mg / day for enough time to
HR be maintained at 60 beats / min or less; and Group B
(control), which received no medication. The protocol of
per- and postoperative care was applied to both groups.
The surgical procedure took place under local
anesthesia with sedation and spontaneous ventilation.
Cardiovascular monitoring was performed with a heart
monitor, and the respiratory, with pulse oximetry. We used
0.5% lidocaine with 1: 400,000 epinephrine for infiltration
in a dose of 10 mg / kg. The anesthetic sedation started
after nasal inspection and use local vasoconstrictor. It was
carried out with midazolam 2-15mg total dose; Propofol
30ml / h was given by infusion pump, plus 3ml IV bolus
when needed; 5-15mg total dose ketamine; Fentanyl
(25mcg) 0,5-1,5ml total dose; clonidine (75mcg) 0.5ml in
the beginning and 0.5ml more at the end of the operation
should BP be over 120 / 80 mmHg; a #7 nasopharyngeal
tube was used after prior lubrication with 20% lidocaine
gel. We also used a urinary Foley catheter for continuous
drainage of urine. We used tramadol 50mg IV for analgesia,
the antiemetics bromopride 2ml (5 mg / ml) IV and
ondansetron (2 mg / ml) 4ml IV and low molecular weight
anticoagulant enoxaparin 0.4 ml (40 mg) SC at the end of
the operation and 18-23mmHg anti-thrombus elastic
stocking.
The procedures used to rejuvenation were:
conventional facelift with temporal-precapillary incision;
preauricular-pre-tragus and retroauricular pre- and
transcapillary, detachment of the skin flaps and frontal (su-
perior)  and slightly oblique traction of these flaps with
plication of the SAMS (Superficial Aponeurotic Muscle
System). Furthermore, we held blepharoplasty by the
classical technique and application of fractional CO
2
 laser
in the central region of the face in three passes with 15
mega joules (MJ) energy  in the non-detached area and
one pass with  10MJ in the detached region. The procedures
were strictly the same in both groups and the mean
operation time was four hours. Hemostasis was strict using
electrocautery. We used a continuous aspiration 3.2 Jackson-
Pratt drain for 24 hours and an occlusive and lightly
compressive dressing with absorbent cotton and bandage.
In the immediate postoperative period, sub-lingual captopril
50mg was used when the systolic pressure was greater
than 120mmHg. Analgesia was applied with dipyrone
500 mg / ml IV q.i.d., antiemesis with bromopride 2ml (5
mg / ml) for IV t.i.d. and ondansetron 4ml (2 mg / mL) IV
b.i.d., and levomepromazine 25mg in the form of sub-lin-
gual drops when needed. The hospital stay was 24 hours.
After discharge and drian removal, patients were
instructed not to do any physical activity, nor flex or twist
the neck, apply ice packs on the face 4x / day and to remain
with a small occlusive dressing at home until the third PO
day, when all the bandages were removed in the clinic.
The postoperative follow-up occurred on the fifth, tenth,
15th, 30th, 60th and 90th days for local and general
evaluations and provision of new directions for both groups.
Patients in group A maintained the use of atenolol until the
15th postoperative day.
The parameters evaluated were: BP, HR, presence
of hematoma and the need for surgical drainage of
expansive hematoma. On the first day, the assessments
were made one at a time with the aid of specialized nursing.
The recovery time for each patient was evaluated
on an outpatient basis by the same medical team, from
the immediate PO (in-hospital) until the 90th day.
Variables were compared between the groups
using the ANOVA test. Normal variables were presented
as “N” (%) and the differences were compared using the
Student’s t test. Values of p d” 0.05 were considered
significant.
RESULTS
Data regarding the frequencies of gender, age,
mean and standard deviation of BP, HR, presence of he-
matoma and need for drainage are shown in table 1.
Twenty-six patients were allocated to group A
(study) and 54 patients to group B (control). In group A, the
mean BP in the first day was 110-70 mmHg and HR was
64 / min. In the evaluations of the third day they remained
the same. In the fifth, tenth and fifteenth days they were
120-80 mmHg and 60 / min, and evaluations of 30 and 60
days showed  130-90 mmHg and 74 / min, respectively.
There was no expansive hematoma in any of
the evaluated moments (first, third, fifth, tenth, 15th, 30th,
60th and 90th days). In only one case there was a left
retroauricular seroma, which was drained with a fine needle
aspiration on the tenth day.
The mean recovery time was considered normal
by the team. All patients were already moving the neck
normally after 15 days and returned to normal activities
between 15 and 30 days. After the 60th day, they were
released to daily physical activities and showed no edema
or any change in skin, nor scars.
In group B, the average BP on the first day 135-
90 mmHg, and HR, 76 / min. Six patients had BP peaks of
150-100mmHg and had to receive sub-lingual captopril to
control them. There were three expansive unilateral he-
matomas (two female patients and one male) that were
drained in the operating room with sedation in the
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immediate postoperative period between six and seven
hours after the operation. The mean BP in the third, fifth
and tenth days was 140-100mmHg and, from the 15th day
on, 130-90mmHg.   The average HR in the third, fifth,
tenth and fifteenth day was 72 / min.
One female patient had a hypertensive crisis in
the 12th postoperative day, with BP levels of 180-120mmHg
and HR 98 / min, and developed a large late unilateral he-
matoma, requiring immediate surgical drainage.
The recovery time of patients in group B (control)
who did not display expanding hematoma was similar to
group A (Atenolol). However, the two patients with
expanding hematoma in the immediate postoperative period
who belonged to group B had a slight delay in healing on
the affected side due to epitheliolisys of the edge of the
flap and had prolonged edema. The patient with late
expansive hematoma had necrosis of the skin flaps of the
retroauricular portion on the affected side and she only
returned to normal activities after 90 days postoperatively.
Because of the prolonged edema, epithelialization occurred
definitively only after 90 days. Two surgical procedures were
needed for correction of the scar on the sixth and twelfth
months.
DISCUSSION
There is no consensus about the best anesthesia
to be used for a facelift. Several authors use general
anesthesia in their services3,4,8,10. The anesthesia performed
in this study was sedation associated with local infiltrative
anesthesia with lidocaine, also used by other authors2,11.
Endotracheal intubation and reflexes triggered by general
anesthesia can cause arrhythmias, reflex hypertension and
bleeding, with hematoma formation. Adequate control of
these reflexes can be obtained using atenolol, as has been
shown in some studies 12,13. Despite this, we still prefer the
technique of local anesthesia with sedation, which proved
to be safe and effective. There were no complications
related to this technique. Whereas the operated patients
are of more advanced age and usually have cardiovascular
or metabolic comorbidities, using general anesthesia should
be questioned. A comparison between the technique of
local anesthesia + sedation with general anesthesia
demonstrates that the latter may have advantages such as
better ventilation and less perioperative bleeding. However,
using a nasopharyngeal tube during sedation ensures airway
permeability and the increased tendency to bleeding is
minimized by the effect of atenolol. A recent study
comparing the two techniques showed that local anesthesia
has fewer unwanted reflexes, less propensity to arrhythmias
or tachycardias, less tendency to vomiting, agitation, and
especially fewer lung complications 14.
In this study, we used low molecular weight
heparin at the end of the operation in association with 18-
23mmHg elastic stockings. It is believed that the use of
anticoagulants very close to the start of the operation
increases the incidence of hematoma1. Some authors
demonstrated that their use at the end of the operation
does not influence operative bleeding 10,15.
In the sample studied, regardless of whether or
not the atenolol was used, there were no coagulation
disorders that may have been attributed to the use of
anticoagulant. Again, considering age, comorbidities,
prevention of venous thrombosis and cardiovascular
protection were important points to be preserved.
Several surgical strategies have been used in
order to prevent the expanding hematoma, such as the
use of a suction drain 4, but the consensus is that the drains
do not prevent nor treat the hematoma 3,7. Another option
is the tumescent infiltration 4, which reduces the use of
adrenaline and “rebound” vasodilation, with the possibility
of reducing bleeding and bruising postoperatively. However,
if the patient has high blood pressure or heart rate, bleeding
may occur 16. Other strategies, such as external stitches2,
use of tissue adhesives5 and the use of internal adhesion
stitches7 are mechanical forms to reduce the “dead space”,
but may not control the bleeding and expanding hemato-
Table 1 - Results (values) obtained (Mean ± SD) after rhytidectomy in 80 patients  observed for 90 days.
Group A (26) Group B (54)
Ateno lo l Cont ro l
Age (Mean) 51.5 (± 6.9) 54.2 (± 8)
Gender Female: 25 = 96.15% Female: 52 = 96.3%
Male: 1 = 3.85% Male: 2 = 3.7%
Blood pressure (Average) 110-65mmHg (± 7.07) 135-90mmHg (± 10.6)
Heart Rate (Average) 64/min (± 5) 76/min (± 7.5)
Expansive Hematoma 0 4 = 7.4% (± 25)
Reoperation for drainage of hematoma 0 4 = 7.4% (± 25)
Blood pressure (Average): Group A <Group B (p < 0.05);
Pulse Rate (Average): Group A <Group B (p < 0.05);
Expansive hematoma: Group A <Group B (p < 0.001);
Reoperation for drainage of hematoma: Group A <Group B (p < 0.001)
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ma if the patient has a peak of hypertension. Also,
mechanical maneuvers may cause retractions or
irregularities in the skin 8. In patients analyzed in this
study, we carried out a thorough and careful hemostasis
with electrocautery with the patient under local
anesthesia and sedation, with BP stable at 120-80mmHg
(and not with induced hypotension) and heart rate 60
bpm. Furthermore, we have used a 3.0 Jackson-Pratt
vacuum suction drain and a slightly compressive, occlusive
dressing.
The rhytidectomy postoperative pain is generally
neglected 16 and  can cause a dangerous cycle consisting
of pain, increased blood pressure, nausea and vomiting
and may even reach anguish and restlessness, as shown by
a study 17. All these factors may recur and evolve
incrementally and even ultimately contribute in important
ways to the appearance of expanding hematoma. Patients
in this study reported no significant pain in any of the
observed times. Even in the four patients in group B who
had expansive and hematoma requiring surgical drainage,
the report was discomfort and swelling.
Studies3,10,16 have systematically related bleeding
and expanding hematoma to increased BP. The “reactive
hypertension” is described after about three to five hours
of facial rhytidectomy, which manifests as increased blood
pressure and affects mainly older patients, a group in which
this procedure is prevalent 16.
We believe that there is a “hematoma cycle” in
which predisposing factors such as advanced age, propensity
to increased blood pressure and preoperative anxiety
associated with triggering factors, such as pain, increased
blood pressure, vomiting, urinary bladder fullness and
psychomotor agitation, can together contribute to the
formation of expanding hematoma.
In this context we proposed the use of atenolol,
which belongs to the propanolamines group and has
antihypertensive and bradycardic action.
An important study analyzing 38,779 operations
in 12 years in patients with high surgical risk in other specialty
operations clearly demonstrated the benefits of atenolol
and the low occurrence of adverse effects 18. Even being a
group of different risk than that of the ones habitually seeking
plastic surgery, it is believed that these benefits can be
achieved in all medical specialties.
Beta-blockers have been used to induce
hypotension and relative bradycardia by intravenous infusion
during facial sinuses operations 19. Another study
demonstrated the perioperative efficacy of intravenous beta-
blockers as antiarrhythmics (no depression in myocardial
contractility), and in hypertensive response, which
occasionally occurs after endotracheal intubation due to
reflex tachycardia 13. The same report showed drastic
reduction in perioperative bleeding with preoperative oral
beta-blockers. It was shown that beta-2 receptors blockers
reduce the production of cytokines by macrophages,
attenuating the inflammatory response induced by surgical
trauma 20 Beta-blockers have been used in the prevention
of bleeding from esophageal varices, with promising results
demonstrated in a meta-analysis 21.
Atenolol shows significant inhibition of the vagal
reflexes during stress, its peripheral nervous effect being
more important than the central one. Its action starts one
hour after the oral use and it has renal excretion, which is
not influenced by phenotypes 18,22. The oral use was for a
period of one to 45 days before, and seven days
postoperatively, in high-risk patients, at the dose of 25-
50mg, displaying success 23.
In this study, atenolol was used in a protocol that
started preoperatively (until HR = 60 bpm) and remained
until 15 days PO; it was taken once a day, with doses
ranging from 25-100 mg, there being no occurrence of
expansive hematoma. In the control group, one patient
had a hypertensive crisis, with formation of expansive he-
matoma on the 12th postoperative day. The fact is a
justification for the use of atenolol until at least 15 days
postoperatively of rhytidectomy.
One patient in group A had significant bradycardia
and hypotension in the eighth postoperative day and the
medication was suspended, but was not excluded from the
present study. Another patient in group A had increased
levels of blood glucose after showing symptoms of diabe-
tes on the 15th postoperative day, and the dose of atenolol
was reduced to 25 mg / day.
It is estimated that in 25-30% of overall
postoperative periods  there is nausea and vomiting 17; this
rate in females is 1.5 to 3.0 times more than in males. As
most patients undergoing rhytidectomy are female, we
believe it is essential to give them ondansetron in the first
24 hours. Patients observed in this study did not have nausea
or vomiting and no symptoms of adverse effect resulting
from its use. Even in the four patients in Group B who had
expansive hematoma requiring surgical drainage, the
presence of this reflex was not observed.
Two authors observed agitation and anxiety in
the PO of rhytidoplasties 10,24. It is believed to be due to
anesthesia or related to the the pain cycle. Generally they
are associated with increased blood pressure and vomiting,
and may contribute to the formation of expansive hemato-
ma. Therefore, clonidine IV to contain the increase in BP
has been recommended in the first 24 hours 10,24. Atenolol
was effective to contain the pre-anesthetic reflexes and
stop the cycle of pain, controlling high BP and vomiting,
due to its action on alpha and beta-1 receptors for a period
of at least 15 days 12.
Bladder plenitude is recognized as an important
trigger of discomfort, psychomotor agitation and
hypertensive crisis in the perioperative period25. The
preventive use of urinary Foley catheter in order to
continuously empty the bladder and prevent bladder globe
was a simple and safe way to reduce the risk of agitation
and anxiety and prevent a possible cycle of expansive he-
matoma.
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Our data suggest that the use of atenolol was
effective in controlling the cycle of hematoma in facial
rhytidectomy and promote shorter recovery time, decrease
the chances of other adverse effects and provide a better
cosmetic result. We must, however, emphasize that the
other measures associated with pain control, nausea and
vomiting, agitation, anxiety and even emptying of the
bladder with indwelling catheters were important preventive
points in the genesis of hypertension. Studies with larger
samples and clinical evaluations of quantitative variables
can corroborate more emphatically the information
contained herein.
R E S U M O
Objetivo: avaliar o uso perioperatório do atenolol na redução da incidência de hematoma pós-ritidoplastia. Métodos: entre
janeiro de 2007 e fevereiro de 2013 foram randomizados 80 pacientes em dois grupos: Grupo A (n=26) recebeu atenolol
perioperatório com objetivo de manter frequência de pulso (FP) ± 60 por minuto, Grupo B (n=54) não recebeu atenolol. Ambos
os grupos foram submetidos à mesma técnica anestésico-cirúrgica. A pressão arterial (PA) e FP, formação de hematoma e a
necessidade de drenagem foram monitorizados. Houve seguimento até o 90º dia de pós-operatório. As variáveis foram
analisadas entre os dois grupos utilizando-se o teste de ANOVA. As variáveis contínuas foram apresentadas como média (±
Desvio-padrão) e as diferenças foram comparadas utilizando-se o t de Student. Foram considerados significantes os valores
p<0,05. Resultados: as médias no grupo A de PA (110-70mmHg ± 7,07) e FP (64 /min ± 5) foram menores (p<0,05) em relação
ao grupo B (135-90mmHg ± 10,6) e (76/min ± 7,5), respectivamente. Houve quatro casos de hematoma expansivo no grupo B,
todos com necessidade de reoperação para a sua drenagem e nenhum no grupo A (p<0,001). Conclusão: o uso do atenolol
perioperatório promoveu a redução de pressão arterial e frequência de pulso e diminuiu a incidência de hematoma expansivo
pós-ritidoplastia.
Descritores: Antagonistas adrenérgicos beta. Isquemia. Hematoma. Ritidoplastia. Face.
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